|Articles|June 28, 2018
A Game-Changer in Diabetic Retinopathy
Advertisement
Having trouble viewing?
Trouble viewing this PDF?
Once you access the file, position your mouse over the top middle for a toolbar:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Phase 1 trial findings confirm safety and tolerability of Huons’ dry eye therapy
5











































.png)


